PNPLA8
Basic information
Region (hg38): 7:108470416-108569666
Links
Phenotypes
GenCC
Source:
- mitochondrial myopathy-lactic acidosis-deafness syndrome (Moderate), mode of inheritance: AR
- mitochondrial myopathy-lactic acidosis-deafness syndrome (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Mitochondrial myopathy with lactic acidosis | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Biochemical; Musculoskeletal; Neurologic | 25512002 |
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (193 variants)
- Inborn genetic diseases (62 variants)
- Mitochondrial myopathy-lactic acidosis-deafness syndrome (18 variants)
- not specified (3 variants)
- PNPLA8-related condition (3 variants)
- Abnormality of the musculature (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PNPLA8 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 49 | 56 | ||||
missense | 139 | 143 | ||||
nonsense | 5 | |||||
start loss | 0 | |||||
frameshift | 9 | |||||
inframe indel | 1 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region ? | 2 | 1 | 3 | |||
non coding ? | 20 | 28 | ||||
Total | 8 | 5 | 145 | 73 | 11 |
Highest pathogenic variant AF is 0.0000263
Variants in PNPLA8
This is a list of pathogenic ClinVar variants found in the PNPLA8 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
7-108472444-T-C | Uncertain significance (Oct 17, 2022) | |||
7-108472458-A-G | Benign/Likely benign (Jan 29, 2024) | |||
7-108472473-CAG-C | Mitochondrial myopathy-lactic acidosis-deafness syndrome • not specified | Conflicting classifications of pathogenicity (Jul 12, 2022) | ||
7-108472481-T-A | Uncertain significance (Jun 07, 2022) | |||
7-108472486-TCTTGA-T | Pathogenic (Mar 21, 2023) | |||
7-108472494-T-C | Likely benign (Sep 01, 2023) | |||
7-108472523-G-A | Inborn genetic diseases | Likely pathogenic (Dec 14, 2023) | ||
7-108472538-T-G | Uncertain significance (Aug 09, 2022) | |||
7-108472551-T-C | Likely benign (Dec 08, 2021) | |||
7-108472557-C-A | Uncertain significance (Jul 12, 2022) | |||
7-108472583-G-A | Pathogenic (Jul 07, 2023) | |||
7-108472589-C-T | Mitochondrial myopathy-lactic acidosis-deafness syndrome | Uncertain significance (Dec 17, 2018) | ||
7-108472616-C-T | Uncertain significance (Jun 27, 2022) | |||
7-108472618-G-A | Uncertain significance (Jul 19, 2022) | |||
7-108472629-A-G | Likely benign (Aug 28, 2023) | |||
7-108472633-T-C | Inborn genetic diseases | Uncertain significance (Dec 14, 2021) | ||
7-108472640-C-T | Inborn genetic diseases | Uncertain significance (Sep 01, 2021) | ||
7-108472653-G-T | Likely benign (Oct 07, 2022) | |||
7-108472680-T-C | Likely benign (Jun 15, 2023) | |||
7-108472684-G-C | Likely benign (Oct 17, 2022) | |||
7-108472689-A-G | Likely benign (Nov 13, 2023) | |||
7-108472689-A-T | Likely benign (Jul 18, 2022) | |||
7-108479166-G-A | Likely benign (Aug 29, 2023) | |||
7-108479173-A-G | Likely benign (Aug 07, 2023) | |||
7-108479196-T-C | Uncertain significance (May 13, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
PNPLA8 | protein_coding | protein_coding | ENST00000422087 | 9 | 99245 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0110 | 0.989 | 125717 | 0 | 23 | 125740 | 0.0000915 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.0949 | 395 | 400 | 0.987 | 0.0000199 | 5127 |
Missense in Polyphen | 69 | 82.715 | 0.83419 | 1135 | ||
Synonymous | 0.574 | 128 | 137 | 0.938 | 0.00000647 | 1461 |
Loss of Function | 3.77 | 10 | 33.6 | 0.297 | 0.00000182 | 456 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000504 | 0.000491 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000164 | 0.000163 |
Finnish | 0.000139 | 0.000139 |
European (Non-Finnish) | 0.0000627 | 0.0000615 |
Middle Eastern | 0.000164 | 0.000163 |
South Asian | 0.0000327 | 0.0000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Calcium-independent phospholipase A2, which catalyzes the hydrolysis of the sn-2 position of glycerophospholipids, PtdSer and to a lower extent PtdCho. Cleaves membrane phospholipids. {ECO:0000269|PubMed:10744668, ECO:0000269|PubMed:15695510}.;
- Pathway
- Eicosanoid Synthesis;Metabolism of lipids;Metabolism;phospholipases;Acyl chain remodelling of PC;Glycerophospholipid biosynthesis;Phospholipid metabolism;Acyl chain remodelling of PE
(Consensus)
Recessive Scores
- pRec
- 0.105
Intolerance Scores
- loftool
- 0.279
- rvis_EVS
- -0.42
- rvis_percentile_EVS
- 25.79
Haploinsufficiency Scores
- pHI
- 0.221
- hipred
- N
- hipred_score
- 0.492
- ghis
- 0.536
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.632
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Pnpla8
- Phenotype
- mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); cellular phenotype; homeostasis/metabolism phenotype; growth/size/body region phenotype;
Gene ontology
- Biological process
- prostaglandin biosynthetic process;fatty acid metabolic process;cell death;arachidonic acid metabolic process;phosphatidylcholine catabolic process;phosphatidylcholine acyl-chain remodeling;phosphatidylethanolamine acyl-chain remodeling;linoleic acid metabolic process;phosphatidylethanolamine catabolic process;arachidonic acid secretion
- Cellular component
- Golgi membrane;peroxisome;peroxisomal membrane;endoplasmic reticulum membrane;membrane;integral component of membrane;perinuclear region of cytoplasm
- Molecular function
- lysophospholipase activity;phospholipase A2 activity;ATP binding;calcium-independent phospholipase A2 activity